Abstract:Recommended culture methods for monitoring bacterial contamination of H2O, dialysate and bicarbonate concentrate in dialysis centers in the USA involves culturing these fluids for 48 h at 37 °C. A variety of media and commercial culture methods are accepted for monitoring these fluids. Over a 3 month period a comparison was made between an acceptable culture method, tryptic soy agar (TSA) employing the pour plate (PP) technique at 37 °C for 48 h, and PP cultures on standard methods agar (SMA) and R2… Show more
“…Microbiological purity of fluids was assessed through the culture of the 0.45-µm ultrafilter membrane on a poor nutrient (R2A) medium at 20–22°C for 7 days, and expressed as CFU/ml [20,21]. UPW and dialysate were considered suitable according to the international guidelines (22, 23 and ISO 23500:2011 Guidance for the preparation and quality management of fluids for hemodialysis and related therapies) when microbiological count was less than 0.1 CFU/ml.…”
<b><i>Background/Aims:</i></b> On-line hemodiafiltration (HDF) is not yet routinely used in ICUs given the potential risk of microbial contamination of dialysis fluids. We evaluated the safety and the tolerance of its use in our ICU. <b><i>Methods:</i></b> A weekly measurement of bacterial growth (CFU/ml) and endotoxin level (endotoxin units/ml) was performed in dialysis fluids over a 7-year period. Intradialytic hypotensive events and pyrogenic reactions were collected during 466 on-line HDF sessions. <b><i>Results:</i></b> A bacterial count <0.1 CFU/ml was achieved in 977/978, 288/290, and 278/280, and an endotoxin level <0.03 endotoxin units/ml in 564/576, 330/337 and 318/323 ultrapure water, dialysate, and infusate samples, respectively. Seventy-six intradialytic hypotensive events but no pyrogenic reaction occurred. <b><i>Conclusion:</i></b> The great majority of dialysis fluid samples were considered suitable with a 99% compliance rate. Use of on-line HDF, at a large scale of dialysate and infusate flows, is well tolerated and may be safely performed in critically ill.
“…Microbiological purity of fluids was assessed through the culture of the 0.45-µm ultrafilter membrane on a poor nutrient (R2A) medium at 20–22°C for 7 days, and expressed as CFU/ml [20,21]. UPW and dialysate were considered suitable according to the international guidelines (22, 23 and ISO 23500:2011 Guidance for the preparation and quality management of fluids for hemodialysis and related therapies) when microbiological count was less than 0.1 CFU/ml.…”
<b><i>Background/Aims:</i></b> On-line hemodiafiltration (HDF) is not yet routinely used in ICUs given the potential risk of microbial contamination of dialysis fluids. We evaluated the safety and the tolerance of its use in our ICU. <b><i>Methods:</i></b> A weekly measurement of bacterial growth (CFU/ml) and endotoxin level (endotoxin units/ml) was performed in dialysis fluids over a 7-year period. Intradialytic hypotensive events and pyrogenic reactions were collected during 466 on-line HDF sessions. <b><i>Results:</i></b> A bacterial count <0.1 CFU/ml was achieved in 977/978, 288/290, and 278/280, and an endotoxin level <0.03 endotoxin units/ml in 564/576, 330/337 and 318/323 ultrapure water, dialysate, and infusate samples, respectively. Seventy-six intradialytic hypotensive events but no pyrogenic reaction occurred. <b><i>Conclusion:</i></b> The great majority of dialysis fluid samples were considered suitable with a 99% compliance rate. Use of on-line HDF, at a large scale of dialysate and infusate flows, is well tolerated and may be safely performed in critically ill.
“…They are summarized in table 1. Membrane filtration and culture on a poor or simple nutrient medium (R2A, Reasoner 2 Agar; TGE, Tryptone Glucose Extract) has been confirmed to be the more sensitive method to detect bacterial contamination [64]. Cultures will be incubated at room temperature (20-23°C) and observed for 5-7 days [65,66].…”
Dialysate purity has become a major concern in hemodialysis since it has been shown that microbial-derived products were stimulating the production and the release of proinflammatory cytokines in hemodialysis patients. This chronic microinflammatory state induced by hemodialysis has been putatively implicated in the development of dialysis-related pathology. In order to prevent risk related to these offenders and to reduce patient/dialysis interaction, it appears highly desirable to use ultrapure dialysis fluid aiming at sterility and apyrogenicity on a regular basis. Ultrapure dialysate results from a complex chain of production where purity grade relies on the weaker link of this chain. Technical aspects and pitfalls in the production of ultrapure dialysate are summarized in this paper. Production of ultrapure dialysate may be achieved on a routine basis, provided adequate components are used, and hygienic handling is regularly ensured. It includes the use of ultrapure water, clean and or sterile electrolytic concentrates (liquid or powder), implementation of ultrafilters on hemodialysis machines, microbiologic monitoring and hygienic handling of the chain with frequent disinfection. Safety and reliability of ultrapure dialysate production relies on a continuous quality assurance process, where results are coupled to corrective action in a feedback loop process.
“…Of note, the monitoring of such systems is also complicated by differing results of CFU counts dependent upon isolation technique, which will require appropriate techniques for evaluation of maintenance of published standards. 112,117 Peritoneal dialysis equipment. The equipment and fluids necessary for peritoneal dialysis require specific mention.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.